171 related articles for article (PubMed ID: 22747470)
1. Reviews on mysterious vascular endothelial cells in renal allografts.
Yamaguchi Y
Clin Transplant; 2012 Jul; 26 Suppl 24():13-9. PubMed ID: 22747470
[TBL] [Abstract][Full Text] [Related]
2. [The role of endothelial cells in allograft rejection].
Regele H
Pathologe; 2008 Nov; 29 Suppl 2():141-4. PubMed ID: 18820919
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cells as targets of allograft rejection.
Glotz D; Lucchiari N; Pegaz-Fiornet B; Suberbielle-Boissel C
Transplantation; 2006 Jul; 82(1 Suppl):S19-21. PubMed ID: 16829788
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms and role of HLA and non-HLA alloantibodies.
Tinckam KJ; Chandraker A
Clin J Am Soc Nephrol; 2006 May; 1(3):404-14. PubMed ID: 17699239
[TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis.
Colvin RB
J Am Soc Nephrol; 2007 Apr; 18(4):1046-56. PubMed ID: 17360947
[TBL] [Abstract][Full Text] [Related]
7. Chronic renal allograft rejection. Selective involvement of the glomerular endothelium in humoral immune reactivity and intravascular coagulation.
Duijvestijn AM; van Breda Vriesman PJ
Transplantation; 1991 Aug; 52(2):195-202. PubMed ID: 1871789
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat.
Paul LC; Muralidharan J; Muzaffar SA; Manting EH; Valentin JF; de Heer E; Kashgarian M
Am J Pathol; 1998 May; 152(5):1209-23. PubMed ID: 9588890
[TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated rejection in renal allografts: lessons from pathology.
Racusen LC; Haas M
Clin J Am Soc Nephrol; 2006 May; 1(3):415-20. PubMed ID: 17699240
[TBL] [Abstract][Full Text] [Related]
10. Complement activation by anti-endothelial cell antibodies in MHC-mismatched and MHC-matched heart allograft rejection: anti-MHC-, but not anti non-MHC alloantibodies are effective in complement activation.
Diujvestijn AM; Derhaag JG; van Breda Vriesman PJ
Transpl Int; 2000; 13(5):363-71. PubMed ID: 11052273
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of endothelial cell antigens involved in renal allograft rejection.
Rosen-Bronson S; Brasile L; Clarke J; Wagner A; Alijani M; Swanson J; Johnson A
Transplant Proc; 1993 Feb; 25(1 Pt 1):185-6. PubMed ID: 8438267
[No Abstract] [Full Text] [Related]
12. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation.
Carter V; Shenton BK; Jaques B; Turner D; Talbot D; Gupta A; Chapman CE; Matthews CJ; Cavanagh G
Transplant Proc; 2005 Mar; 37(2):654-7. PubMed ID: 15848491
[TBL] [Abstract][Full Text] [Related]
13. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
14. Alloimmunization against platelet antigens in renal transplant patients with acute vascular rejection.
Kekomäki S; Salmela K; Partanen J; Koskimies S; Kekomäki R
Clin Transplant; 1997 Feb; 11(1):19-24. PubMed ID: 9067689
[TBL] [Abstract][Full Text] [Related]
15. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic criteria of antibody-mediated rejection in kidney transplants.
Mosquera Reboredo JM; Vázquez Martul E
Nefrologia; 2011; 31(4):382-91. PubMed ID: 21738242
[TBL] [Abstract][Full Text] [Related]
17. Endothelial activation and chronic allograft rejection.
Orosz CG
Clin Transplant; 1994 Jun; 8(3 Pt 2):299-303. PubMed ID: 7520304
[TBL] [Abstract][Full Text] [Related]
18. Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients.
Boratyńska M; Banasik M; Hałoń A; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2711-4. PubMed ID: 18021965
[TBL] [Abstract][Full Text] [Related]
19. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.
Colovai AI; Vasilescu ER; Foca-Rodi A; Kim-Schulze S; Hussaini N; D'agati VD; Markowitz GS; Wang C; Cohen DJ; Hardy MA; Suciu-Foca N
Hum Immunol; 2005 May; 66(5):501-12. PubMed ID: 15935887
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of chronic allograft rejection.
Joosten SA; van Kooten C; Paul LC
Transpl Int; 2003 Mar; 16(3):137-45. PubMed ID: 12664207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
